跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,871 条关于
“Bioqube Ventures”
全部
1,871
临床试验
907
药物
19
机构
22
资讯
923
6个月前
Commit Biologics Names Serial Biotech Entrepreneur as CEO to Advance Complement-Powered Immunotherapies
7个月前
Primmune Therapeutics Raises $8.6M to Advance TLR7 Agonist PRTX007 into Phase 2 Melanoma Trial
去年
CatalYm Strengthens Leadership Team to Advance Visugromab Through Late-Stage Development
去年
Spica Therapeutics Secures €1 Million VLAIO Grant to Advance Anti-CD163 Monoclonal Antibody for Cancer Treatment
去年
Commit Biologics Forms Scientific Advisory Board to Advance Complement-Based Cancer and Autoimmune Therapies
去年
SynOx Therapeutics Completes Enrollment in Phase 3 Trial of Emactuzumab for Rare Joint Tumor
去年
CatalYm's Visugromab Shows Promise in Enhancing Antibody-Drug Conjugate Efficacy by Blocking GDF-15
去年
RBL Secures Investment from Modi Ventures to Accelerate Biotech Venture Creation
上个月
Mercantile Life Science Ventures and Big Idea Ventures Invest in Maia Fertility to Advance Ferizyme™ Platform
上个月
Rare Ventures Launches: A $25 Million Venture Philanthropy Platform to Accelerate Rare Disease Therapies
第 1 页,共 93 页
上一页
下一页